NCT04490603 The Effect of Virtual Reality Experience on Infusion-related Pain
| NCT ID | NCT04490603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University |
| Condition | Virtual Reality |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2020-08-19 |
| Primary Completion | 2024-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2020-08-19 with a primary completion date of 2024-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to analyze the effect of virtual reality experience on infusion-related pain with lumbar epidural catheterization.
Eligibility Criteria
Inclusion Criteria: If all of the following conditions are met * A person with chronic low back pain that lasts more than 3 months due to spinal stenosis or lumbar disc disease. * Adults over 20 * Those who decided to participate out of his/her own free will and signed in written consent Exclusion Criteria: If the patient meets one or more of the following criteria, He or She cannot participate this clinical trial. * In case of contraindication to general lumbar catheterization (e.g. coatulopathy, infection, etc) * Hearing and vision impairments * Affective disorder * History of epilepsy or seizure * If communication is not possible due to impaired cognitive ability * Those who have been deemed inappropriate by the researchers
Contact & Investigator
Jee Youn Moon, PhD
STUDY DIRECTOR
Associate Professor
Frequently Asked Questions
Who can join the NCT04490603 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Virtual Reality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04490603 currently recruiting?
Yes, NCT04490603 is actively recruiting participants. Contact the research team at jymoon0901@gmail.com for enrollment information.
Where is the NCT04490603 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT04490603 clinical trial?
NCT04490603 is sponsored by Seoul National University. The principal investigator is Jee Youn Moon, PhD at Associate Professor. The trial plans to enroll 72 participants.